Margaret Kasner - Concepedia

Author

Margaret Kasner

Also Known As

Kovak, Matthew R, M KASNER, M Kasner, M T Kasner, M. Kasner, M., Kasner, Margaret Kasner, Margaret T Kasner, Margaret T. Kasner

164

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University University of Pennsylvania Sidney Kimmel Cancer Center Asan Medical Center Charité - Universitätsmedizin Berlin

About

Margaret Kasner is an author at Thomas Jefferson University specializing in medicine, radiation oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	455
2	Health Sciences	5	5	174
3	Cell Biology	3	3	228
4	Blood Transplantation	2	2	46
5	Public Health	1	1	17

Margaret Kasner

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes, New England Journal of Medicine	2019	1.2K
High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction Carsten Tschöpe, C.–Thomas Bock, Margaret Kasner, Circulation	2005	252
The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice Jennifer Oliver‐Krasinski, Margaret Kasner, Juxiang Yang, Journal of Clinical Investigation Systems BiologyDevelopmental BiologyTranscriptional NetworkTranscription Factor NetworkPancreatic Cancer	2009	173
Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure Rolf Wachter, Stephan Schmidt‐Schweda, Dirk Westermann, European Heart Journal	2009	120
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia Alexander E. Perl, Margaret Kasner, Donald E. Tsai, Clinical Cancer Research	2009	102
Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis Margaret Kasner, Regina Gaub, David Sinning, European Journal of Echocardiography	2010	87
Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts) Karen Yee, Giovanni Martinelli, Norbert Vey, Blood	2014	82
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing Dolores Grosso, Matthew Carabasi, Joanne Filicko-O’Hara, Blood	2011	75
Clostridium Difficile Colonization and Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation Jackrapong Bruminhent, Zixuan Wang, Carol Hu, Biology of Blood and Marrow Transplantation	2014	75
Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts during a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensive Chemotherapy Alexander E. Perl, Margaret Kasner, Doris Shank, Clinical Cancer Research	2011	53

Page 1